Result highlights include: Revenue up 27% or $856K to $4.039M Expenses reduced by 12% or $0.69M to ($5.2M) EBITDA up 58% or $1.5M to ($1M) Innovation investments (R&D) increase 84% to $1.468M Global Health Limited (ASX: GLH) (“Global Health” or “the Group”) is pleased to release...
Global Health is excited to present our Annual Report, showcasing our achievements in the past year. The highlights include: 20% increase in Customer Revenue to $7.81 million 11% growth in Annual Recurring Revenue reaching $5.73 million 47% rise in Gross Margin, totaling $4.12 million. In addition, we...
Read the 2020 Annual Report to Shareholders here...
Read the 2020 Appendix 4E and Full Year Statutory Accounts: 2020 Appendix 4E and Full Year Statutory Accounts View on the ASX here: Appendix 4E and Full Year Statutory Accounts ...
Read the 2019 Annual Report to Shareholders here: 2019-09-GH 2019 Annual Report to Shareholders...
Please view the annual report via this link: Annual Report Global Health Limited...
Please view the annual report via this link: Annual Report Global Health Limited...
Please view the annual report via this link: Annual Report Global Health Limited...
Please view the annual report via this link: Annual Report Global Health Limited...